Insight Strategy Advisors is a boutique management and strategy consulting firm specializing in healthcare and the life sciences with strengths in pricing & contracting, market access, reimbursement, specialty distribution, oncology, companion Dx and specialty products.Responsibilities included leading firm growth and the development of service offerings (e.g., specialty distribution) as well as generating over $2.0M+ in annual sales and leading engagements valued at over $4.0M+ annually for engagements covering market access strategies that include pricing & contracting, reimbursement, specialty distribution, and value proposition - Managed over 100+ engagements assisting clients understand market stakeholders, different market environment scenarios, competitive dynamics and the patient journey. Projects included detailed assessments covering a variety of customer segments, including commercial managed care, the Federal market, state Medicaid programs, hospitals, IDNs/ACOs, employers, FQHCs, medical groups, GPOs, retail and specialty pharmacies, and distributors.- Led 50+ projects assisting clients in the development of pricing and contracting strategies for small molecule and biologics in competitive and orphan market environments. Engagements involved qualitative and quantitative research with global payers, physicians, patients and other key stakeholders - Advised on the development of reimbursement, access and specialty distribution strategies and plans for 75+ potentially new biologic and orphan products. Strategies and plans ranged from market assessments, strategy option evaluations and implementation support projects

Senior Practice ExecutiveAugust 2009 – March 2011 (1 year 8 months)Practice ExecutiveFebruary 2007 – July 2009 (2 years 6 months)Associate Practice ExecutiveAugust 2006 – January 2007 (6 months)Senior ConsultantJuly 2005 – July 2006 (1 year 1 month)Responsibilities include generating over $2.7M in annual sales and managing engagements valued at over $4.3 million annually for market access and specialty distribution engagements while growing a team from 3 consultants to over 20 consultants. Representative projects include:- Led strategic planning activities covering key customer segments for two top 5 pharmaceutical manufacturers- Led the development of a pricing and contracting strategy for a product indicated to treat allergic rhinitis- Advised on the development of a reimbursement, access and specialty distribution strategy for an ultra-orphan product- Led the design and development of a specialty distribution strategy for an oral oncology agentSample of Therapeutic Areas and Drug Class Experiences Include: - In-Line Products: Immunotherapy, Anaphylaxis, Dyslipidemia, Fertility, Hemophilia, HCV, HGH, Insomnia, IV Iron, Multiple sclerosis, Oncology, Osteoporosis, Opioids, Rheumatoid Arthritis, Mental Health - Pre- and At-Launch Products: Orphan products, Alzheimer's, Allergic Rhinitis, Antibiotics, Antipsychotics, Antiplatelet, Asthma/COPD, Atrial fibrillation, Cystic fibrosis, Epilepsy, HCV, HIV, Hypertension, Insomnia, Transplant, Oncology, Overactive Bladder, Mental Health, Muscular Dystrophy, Multiple Sclerosis, Parkinson’s

Responsibilities included marketing management, growth strategy development, process design, market opportunity assessment, portfolio valuation, and efficiency & capacity analysis.

Primary Responsibilities: * Developing and analyzing business operating models and strategies which include financial, competitive, and industry trend analyses as well as project valuations, business case management, customer/market segmentations, internal and external operating model assessments, stakeholder communications, balance scorecard development, macro/micro economic assessments, and senior executive reporting.Representative Engagements:* Managed a $250 million global supply chain business case for a major quick service restaurant corporation.* Created a project evaluation financial model related to an operations strategy assessment for an electronic component distribution company.* Conducted a go-to-market strategy study for the services' division of a major computer manufacturer entering the financial services sector.* Formulated a strategic assessment on a web-based product concept for a large telecommunications company.

As a financial analyst on the US Fixed Income Sales and Trading desk, responsibilities included: * Facilitated the issuance of more than $1B in customized fixed income structured products.* Managed the global capital markets needs of clients in coordination with the institutional sales and trading group.* Executed fixed income derivative transactions resulting in over $3M in revenue for a $10B portfolio.* Established 30 inter-bank relationships resulting in over $350K in hedge cost savings.* Conducted a valuation study of a $500M derivative portfolio for market risk exposure, which served as the basis for executing business strategies during the Asian financial crisis.* Achieved Series 7 and Series 63 certification